Molecular Cloning and Transient Expression of Recombinant Human PPARγ in HEK293T Cells Under an Inducible Tet-on System
- 55 Downloads
Peroxisome proliferator-activated receptor gamma (PPARγ) is involved in the regulation of lipid and glucose homeostasis and inflammation. PPARγ expression level has been widely studied in multiple tissues; however, there are few reports of preceding attempts to produce full-length human PPARγ (hPPARγ) in cellular models, and generally, expression level is not known or measurable. We propose an alternative strategy to express recombinant hPPARγ1, using a transient transfection with an inducible Tet-On 3G system where target and reporter gene were cloned in the same open reading frame. We transiently co-transfected human embryonic kidney 293T (HEK293T) cells with pTRE-ZsGreen1-IRES2-hPPARγ1 and pCMV-TET3G for inducible expression of hPPARγ1. Relative expression of the transcript was evaluated by RT-qPCR 48 h after transfection, obtaining a high expression level of hPPARγ (530-fold change, p < 0.002) in co-transfected HEK293T cells in the presence of doxycycline (1 μg/mL); also a significantly increased production of the reporter protein ZsGreen1 (3.6-fold change, p < 0.05) was determined by fluorescence analysis. These data indicated that HEK293T cells were successfully co-transfected and it could be an alternative model for hPPARγ expression in vitro. Additionally, this model will help to validate the quantification of inducible hPPARγ expression in vivo models for future research.
KeywordsCellular model Inducible expression PPARγ Transfection qPCR
Human peroxisome proliferator-activated receptor gamma
Human embryonic kidney 293T
SMM thanks CONACYT-MEXICO for the Grant [No. 307119] and also thank Elizeth Pioquinto-Avila for technical support.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Berger, J., & Moller, D. E. (2002). The mechanisms of action of PPARs. Annual Review of Medicine, 53, 409–435. https://doi.org/10.1146/annurev.med.53.082901.104018.CrossRefGoogle Scholar
- 9.Shim, J., Kim, B., Kim, B. H., Il, Y., & Kim, K. Y. (2010). The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells. International Journal of Oncology, 36, 223–231. https://doi.org/10.3892/ijo_00000493.Google Scholar
- 10.Chan, S. H., Wu, K. L., Kung, P. S., & Chan, J. Y. (2010). Oral intake of rosiglitazone promotes a central antihypertensive effect via upregulation of peroxisome proliferator-activated receptor-gamma and alleviation of oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertension, 55, 1444–1453. https://doi.org/10.1161/HYPERTENSIONAHA.109.149146.CrossRefGoogle Scholar
- 13.Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995). An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). Journal of Biological Chemistry, 270, 12953–12956. https://doi.org/10.1074/jbc.270.22.12953.CrossRefGoogle Scholar
- 14.Zhu, Z., Zheng, T., Chun, G., Homer, R. J., & Elias, J. A. (2002). Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling. Seminars in Cell & Developmental Biology, 13, 121–128. https://doi.org/10.1016/S1084-9521(02)00018-6.CrossRefGoogle Scholar
- 17.Elbrecht, A., Chen, Y., Cullinan, C. A., Hayes, N., Leibowitz, M., Moller, D. E., et al. (1996). Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochemical and Biophysical Research Communications, 224, 431–437. https://doi.org/10.1006/bbrc.1996.1044.CrossRefGoogle Scholar
- 18.Relic, B., Benoit, V., Franchimont, N., Kaiser, M. J., Hauzeur, J. P., Gillet, P., et al. (2006). Peroxisome proliferator-activated receptor-gamma1 is dephosphorylated and degraded during BAY 11-7085-induced synovial fibroblast apoptosis. Journal of Biological Chemistry, 281, 22597–225604. https://doi.org/10.1074/jbc.M512807200.CrossRefGoogle Scholar
- 19.Guo, F., Ren, X., Don, Y., Hu, X., Xu, D., Zhou, H., et al. (2016). Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-Catenin signaling pathway downstream target genes TERT and ENAH. Gene, 584, 31–37. https://doi.org/10.1016/j.gene.2016.03.003.CrossRefGoogle Scholar
- 22.Ma, J., Zhang, T., Fang, N., Zou, Y., Gong, Q., Yu, L., et al. (2012). Establishment of a cell-based drug screening model for identifying agonists of human peroxisome proliferator-activated receptor gamma (PPARγ). Journal of Pharmacy and Pharmacology, 64, 719–726. https://doi.org/10.1111/j.2042-7158.2012.01462.x.CrossRefGoogle Scholar
- 25.Tachibana, K., Kobayashi, Y., Tanaka, T., Tagami, M., Sugiyama, A., Katayama, T., et al. (2005). Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms. Nuclear Receptors, 3, 3. https://doi.org/10.1186/1478-1336-3-3.CrossRefGoogle Scholar
- 26.Ju, Z., Su, M., Hong, J., Ullah, S., Kim, E. L., Zhao, C., et al. (2018). Design of PPAR-γ agonist based on algal metabolites and the endogenous ligand 15-deoxy-Δ12, 14-prostaglandin J2. European Journal of Medicinal Chemistry, 157, 1192–1201. https://doi.org/10.1016/j.ejmech.2018.08.090.CrossRefGoogle Scholar